The FDA has updated its master protocol guidance to include new instructions on basket trials, aiming to accelerate the development of precision medicines.
HHS has unveiled major clinical trial reforms to boost U.S. competitiveness. Learn how these new strategies aim to accelerate drug discovery and research.
The U.S. is fast-tracking early-stage drug research to bolster global competitiveness, streamline medical innovation, and secure the domestic bio-pipeline.
New clinical trial data confirms that transitioning to oral antibiotics for complicated UTIs is safe and effective, promoting better antimicrobial stewardship.
HHS has launched a major initiative to modernize clinical trials, aiming to improve patient diversity, streamline regulations, and boost medical innovation.
Federal health agencies have launched a new strategy to shorten Phase 1 clinical trials by up to a year. Learn how this shift impacts drug development.
The FDA has introduced a new pilot program to accelerate early-stage clinical trials, aiming to streamline drug development and improve regulatory efficiency.
Explore how the U.S. and China can balance biotech competition to prioritize global patient outcomes and innovation in this professional health analysis.
Oncology nurses are transforming clinical trial success through strategic delegation and expert planning. Learn how their leadership drives better results.